Please Wait...

Upcoming Webinar: Outsourcing Pharmacovigilance: Pros and Cons and Lessons Learned

Join us for our upcoming webinar on July 25th during which Sukrit Singh and Dr. Ayesha Hussain, both pharmacovigilance experts who are also Associate Directors of CRM at Bioclinica, Inc., will present and discuss case studies illustrating how market authorization holders and CROs are becoming partners of choice in the ever-changing world of pharmacovigilance outsourcing.

The need to comply with regulatory requirements is increasing with the demand for new therapies across the pharmaceutical industry, which is seeking newer, more efficient ways of managing the growing load of adverse event data. Outsourcing is becoming a possible solution for short or long-term needs for more companies because of the:

  • Unavailability of the necessary system components for timely pharmacovigilance implementation by first-time marketing authorization holders.
  • Need for larger companies to streamline processes and reduce wastage, for a more robust and compliant reporting system.

The presented case studies will provide examples of:

  • Streamlining and globalizing processes to increase compliance rates with regulatory agencies.
  • Increasing productivity and reducing time to market.
  • Focusing on data quality.
  • Employing business excellence strategies to identify more effective ways of presenting accurate and meaningful data.
  • Employing tools that help market authorization holders achieve ease of operation and better transparency.

To join us for this webinar and learn more, register here.

Webinar: Outsourcing Pharmacovigilance: Pros and Cons and Lessons Learned

LEARN MORE OR SPEAK WITH OUR EXPERTS

CONTACT US
Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

Hope to see you at DIA's #Pharmacovigilance & Risk Mgmt Strategies Conf. this wk! Visit @Bioclinica in booth 32. Pr… https://t.co/nzEzlJcoL0
bioclinica (17 hours ago)
RT @ConferenceForum: Honored to have @bioclinica as an associate sponsor of 2018 #IO360nyc: https://t.co/ZXdgZTMDqc https://t.co/27mfxg65aT
bioclinica (18 hours ago)
RT @bioclinica: Kevin Bishop, named a 'Top Innovator' in #clinicaltrials by @CenterWatch See how we're reducing risk to the clinical suppl…
bioclinica (18 hours ago)
ASCPT 2018 Annual Meeting https://t.co/i0mjYbBq5N Join @Bioclinica Research's Open House 3/22 https://t.co/citlLotbD7
bioclinica (4 days ago)
Heading to DC for DIA's #Pharmacovigilance & Risk Mgmt Strategies Conf.? Visit @Bioclinica in booth 32. Preview our… https://t.co/alU1sCg04l
bioclinica (4 days ago)
Kevin Bishop, named a 'Top Innovator' in #clinicaltrials by @CenterWatch See how we're reducing risk to the clinic… https://t.co/rXBGvIh9Wr
bioclinica (5 days ago)

Latest Blogs:

Removing Risk from Clinical Trial Management System (CTMS) Implementations
Collaboration Between Clinical Operations and the Logistics and Supply Chain Teams is Key to Trial Success
The Value of Protocol Review
CTMS and RBM: Hot Topics at OCT Nordics in Copenhagen